论文信息 - Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial. - 字舞流文

Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.

J. Olson | M. Ellis | R. Gray | H. Gómez | G. Sledge | S. Paik | C. Geyer | M. Goetz | S. Badve | J. Sparano | D. Hayes | W. Wood | J. Abrams | K. Albain | E. Dees | D. Toppmeyer | M. Keane | A. Brufsky | T. Saphner | I. Mayer | T. Lively | J. Berenberg | V. Kaklamani | L. Wagner | D. Makower | P. Reddy | T. Goggins | C. Desbiens | Catalin Mahalcioiu